DelveInsight’s ‘Diabetic Retinopathy–Market Insights, Epidemiology, and Market Forecast—2032’ report delivers an in-depth understanding of Diabetic retinopathy, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Key Highlights for Diabetic Retinopathy Market
Key Companies working on the Diabetic Retinopathy Market include Genetech, Roch, Ocuphire and many others
Key Therapies included in the Diabetic Retinopathy Market market include OPT-302, RGX 314, Runcaciguat, and many others
Diabetic Retinopathy Market Overview
Diabetic Retinopathy is a common and specific microvascular complication of diabetes and remains the leading cause of preventable blindness in working-aged people. It is identified in a third of people with diabetes and is associated with an increased risk of life-threatening systemic vascular complications, including stroke, coronary heart disease, and heart failure. In the USA, an estimated 40% (8% for vision-threatening retinopathy) of people with type 2 diabetes and 86% (42%) with type 1 diabetes have diabetic retinopathy.
Several large studies have shown that the onset of Diabetic Retinopathy is generally not observed within the first 5 years after the diagnosis of type 1 diabetes. In contrast, the commencement of type 2 diabetes is often more insidious, and as such, the retinal disease may be present at the time of diagnosis. Therefore, screening for Diabetic Retinopathy is recommended at the time of diagnosis in type 2 diabetics. Chronic hyperglycemia and its cardinal parameter, HbA1c, have been directly linked to DR. In this regard, the ophthalmologist plays an essential role by screening patients with diabetes mellitus, motivating them to control their glucose levels, and explaining the sequelae of DR progression, including visual impairment.
Diabetic Retinopathy Market Epidemiology Insights
The total Diabetic Retinopathy prevalent cases in the 7MM were 12,585,769 in 2021.
In 2021, the Diabetic Retinopathy market size in the seven major markets was found to be USD 126,851 million, which is expected to grow by 2032.
Click here to learn more about the Diabetic Retinopathy Market Landscape
The Report Covers the Diabetic Retinopathy Market Epidemiology Segmented by:
Diabetic Retinopathy prevalent cases
Diabetic Retinopathy incident cases
Diabetic Retinopathy treatment cases
Diabetic Retinopathy diagnosed cases
Diabetic Retinopathy Market Market Outlook
The Diabetic retinopathy market outlook of the report helps build a detailed comprehension of the historic, current, and forecasted Diabetic retinopathy market trends by analyzing the impact of current therapies on the market, Diabetic Retinopathy unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the Diabetic retinopathy market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other Diabetic retinopathy therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the Diabetic retinopathy market in 7MM is expected to change in the study period 2019–2032.
Key Companies Working in the Diabetic Retinopathy Market
Genetech
Roch
Ocuphire
And many others
Diabetic Retinopathy Market Therapies Covered and Analyzed in the Report
OPT-302
RGX 314
Runcaciguat
Learn more about the Key Companies and Emerging Therapies in the Diabetic Retinopathy Market Market
Table of Contents
Key Insights
Diabetic Retinopathy Market Introduction
Executive Summary of Diabetic Retinopathy Market
Disease Background and Overview
Epidemiology and patient population
Diabetic Retinopathy Market Emerging Therapies
Market Access and Reimbursement of Therapies
Market Drivers
Market Barriers
Appendix
Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the report @ Diabetic Retinopathy Market Outlook
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Adya KaulEmail: Send EmailPhone: 919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/consulting/due-diligence-services
